Biotech Startups

Arcturis provides research-ready, regulatory-grade real-world health data and analytics for clinical research and drug development, leveraging a UK-based network of enriched electronic health records and multi-modal patient data. The company generates real-world evidence insights to support clinical trials, external control arms, and health technology assessments.

1 investor

1 investor

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

1 investor

Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases. It operates in the biotechnology and therapeutics sector.

1 investor

Ardan Pharma is a biotech company developing small-molecule modulators of the TMEM176A/B cation channel as a targeted cancer immunotherapy for oncology indications with unmet medical needs. Incorporated in Delaware with operations in Uruguay and Argentina, it is advancing drug candidates from pre-IND toward clinical stage.

1 investor

Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.

1 investor

Ardra uses fermentation technology to produce natural ingredients for food, perfumery, and cosmetics from renewable substrates, offering stable pricing and consistent quality independent of seasonal or geopolitical disruptions. The company's approach eliminates environmental and social costs associated with traditional botanical and animal-derived ingredients.

1 investor

B-FLEXION is an investment group with a heritage in biopharmaceuticals spanning three generations, operating asset managers across multiple investment areas and holding stakes in transformative operating businesses.

1 investor

Argenta Global is a contract research and manufacturing organization (CRO/CDMO) specializing in animal health, providing comprehensive support across the product development lifecycle from molecule to market for companion and farm animal treatments.

1 investor

Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners. The company supports biotech innovation through partnerships with leading healthcare and research organizations.

1 investor

Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.

1 investor

Argonaut Manufacturing Services provides contract manufacturing for life sciences and healthcare products, serving partners across the health and biotech industries with expertise in cGMP manufacturing, regulatory affairs, and operational scaling.

1 investor

ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing. Its patented Auga platform combines sensor hardware, sensor chips, and software to track critical quality attributes and process parameters, including in-line detection of antibody aggregates and fragments during purification.

1 investor

Aridhia develops the Digital Research Environment (DRE), a trusted research platform for biomedical and health informatics that enables researchers across multiple countries to collaborate on health research and data-intensive health delivery programs. The platform addresses regulatory compliance, data management, and collaboration challenges in scaling health research initiatives.

1 investor

Ariel Precision Medicine offers an AI-driven platform that integrates genomic and clinical data (including EHR/EMR records, lab results, and scientific literature) to produce peer-reviewed, evidence-based reports. It serves clinicians diagnosing complex diseases and therapeutics developers seeking target discovery and patient stratification.

1 investor

ArisGlobal provides software for life sciences research and development, covering drug development, drug safety monitoring, and regulatory compliance. It serves biopharmaceutical companies, CROs, and government health authorities, working with over 220 global life sciences organizations.

1 investor

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

1 investor

ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.

1 investor

ArmaGen develops blood-brain-barrier-crossing protein therapies for lysosomal storage disorders; acquired by JCR Pharmaceuticals in 2020.

1 investor

ARMGO develops a novel class of therapeutics called Rycals that target ryanodine receptors (RyRs) to correct calcium channel dysfunction in serious diseases with high unmet need. Its lead candidate, Surlorian, is being developed for heart failure by addressing an underlying driver of disease progression.

1 investor

ARMR Sciences is developing conjugate vaccines and biologic countermeasures, including its lead candidate ARMR-100, designed to bind fentanyl in the bloodstream and prevent overdose from synthetic drugs. It targets high-risk populations such as first responders, military personnel, and individuals in recovery, working on a platform approach to address emerging drug threats.</parameter> <parameter name="sector_codes">["biotech", "healthtech", "deeptech"]

1 investor

ARNA Genomics US develops liquid biopsy multiomics diagnostic technologies, with a current focus on ARNA Breast, an assay for early-stage breast cancer detection. The company operates as a research diagnostic laboratory conducting clinical trials on its cancer marker tests.

1 investor

Aroa Biosurgery Limited manufactures medical devices, including Endoform, for surgical applications with coverage under Medicare reimbursement policies.

1 investor

AROMICS develops functional genomics and proteomics technologies for research and development of new therapies and diagnostic products in human health. The company focuses on translational research, personalized medicine, and biomarker identification for the pharmaceutical and diagnostics industries.

1 investor